CA2596303C - Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant - Google Patents

Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant Download PDF

Info

Publication number
CA2596303C
CA2596303C CA2596303A CA2596303A CA2596303C CA 2596303 C CA2596303 C CA 2596303C CA 2596303 A CA2596303 A CA 2596303A CA 2596303 A CA2596303 A CA 2596303A CA 2596303 C CA2596303 C CA 2596303C
Authority
CA
Canada
Prior art keywords
vector
nucleic acid
virus
sequences
native
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2596303A
Other languages
English (en)
Other versions
CA2596303A1 (fr
Inventor
Elazar Rabbani
Dakai Liu
Jeffrey Ng
Lev Lubarsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzo Therapeutics Inc
Original Assignee
Enzo Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzo Therapeutics Inc filed Critical Enzo Therapeutics Inc
Priority claimed from CA2285666A external-priority patent/CA2285666C/fr
Publication of CA2596303A1 publication Critical patent/CA2596303A1/fr
Application granted granted Critical
Publication of CA2596303C publication Critical patent/CA2596303C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

CA2596303A 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant Expired - Lifetime CA2596303C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82296397A 1997-03-21 1997-03-21
US08/822,963 1997-03-21
CA2285666A CA2285666C (fr) 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2285666A Division CA2285666C (fr) 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant

Publications (2)

Publication Number Publication Date
CA2596303A1 CA2596303A1 (fr) 1998-10-01
CA2596303C true CA2596303C (fr) 2013-09-24

Family

ID=38719454

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2596292A Expired - Fee Related CA2596292C (fr) 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant
CA2596303A Expired - Lifetime CA2596303C (fr) 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2596292A Expired - Fee Related CA2596292C (fr) 1997-03-21 1998-03-20 Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant

Country Status (1)

Country Link
CA (2) CA2596292C (fr)

Also Published As

Publication number Publication date
CA2596292C (fr) 2012-05-22
CA2596303A1 (fr) 1998-10-01
CA2596292A1 (fr) 1998-10-01

Similar Documents

Publication Publication Date Title
US20090263895A1 (en) Cell line for producing a non-retroviral vector
WO1998042856A9 (fr) Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant
Hildinger et al. Design of 5′ untranslated sequences in retroviral vectors developed for medical use
JP4190579B2 (ja) 非分裂細胞への核酸運搬のためのベクターおよび使用方法
Mergia et al. Foamy virus vectors
US20140170709A1 (en) Vector for gene therapy
US5576201A (en) Retroviral vector particles for transducing non-proliferating cells
JP2002542834A (ja) レトロウイルスベクターでのｉｒｅｓ転写カセットからの異種遺伝子群の発現
US5580766A (en) Retroviral vector particles for transducing non-proliferating cells
CA2596303C (fr) Vecteurs et vecteurs viraux et lignees de cellules d'encapsidation les propageant
US20060183228A1 (en) Viral vectors with surface or envelope components
US20070037284A1 (en) Vectors for expressing exogenous gene or exogenous nucleic acid sequences
US8703480B1 (en) Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells
EP4286401A1 (fr) Utilisation d'une protéine artificielle ou d'un acide nucléique codant la protéine artificielle pour fournir un complexe de ribonucléoprotéines fonctionnel
US20020164583A1 (en) Targeting viral vectors to specific cells
US8309071B2 (en) Foamy viral envelope genes
Maurya et al. Retroviral vectors and gene therapy: an update
Fichter Development of Novel Transient Delivery Systems for Gene Therapy
US20060067948A1 (en) Viral vectors
Bannerji Genetics and biology of retroviral vectors
EP2138584A1 (fr) Gènes à enveloppe virale mousseuse
WO1996026745A9 (fr) Vecteurs de virus biosynthetiques a usage en therapie genique
WO1996026745A1 (fr) Vecteurs de virus biosynthetiques a usage en therapie genique
Beckert et al. Section ii other therapeutic Strategies
Heusch Preclinical development of ribozyme gene therapy for primate lentiviruses

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180320